According to bluebird bio 's latest financial reports the company's current EPS (TTM) is -0,98 โฌ. In 2022 the company made an earnings per share (EPS) of -3,43 โฌ an increase over its 2021 EPS that were of -11,44 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -1,03 โฌ | -70.07% |
2022 | -3,43 โฌ | -70.04% |
2021 | -11,44 โฌ | 20.1% |
2020 | -9,53 โฌ | -30.47% |
2019 | -13,70 โฌ | 34.11% |
2018 | -10,22 โฌ | 39.3% |
2017 | -7,33 โฌ | 8.5% |
2016 | -6,76 โฌ | 47.08% |
2015 | -4,60 โฌ | 169.66% |
2014 | -1,70 โฌ | -40.95% |
2013 | -2,89 โฌ | 380.01% |
2012 | -0,60 โฌ |